.jpg)
.jpg)
TSH Board of Directors Approved Financial Statements For the Year Ended December 31, 2023
2024.2.27
...
.jpg)
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD., regarding the BOD resolved to convene the 2024 Annual G
2024.2.22
...
TSH announces TFDA acceptance TSH announces TFDA acceptance Tyrvaya® for Dry Eye Nasal Spray, expected approval by late 2024.
2024.1.3
...
.jpg)
TSH Biopharm was invited to attend the institutional investor conference hosted by KGI Securities
2023.12.21
...
.jpg)
To announce the change of financial officer and acting spokesperson of the Company
2023.12.14
...
